Australia's largest stock trading and investment forum Australia's #1 stock forum

TIS

0.00%

0.0¢ tissue therapies limited

NZ company - tissue repair product, page-24

First 24 Last

Share
Profile

Follow
kosenar

1,824 Posts.

4

21/10/14

16:11

Post #: 14157457
Share

Originally posted by timkiely ↑

This is like Ground Hog Day.

1. From the NRMA on classifications.
"It is for the manufacturer to initially determine the classification of their product(s). This will allow them to select a notified body (if required) with the ability to carry out the appropriate conformity assessment procedure. It will then be for that notified body to confirm the classification arrived at by the manufacturer before embarking upon the process of conformity assessment."
I hope that is clear enough.\

2.
Question: Why was Medical Device Rule 8 chosen for the regulatory submission instead of Device Rule 13?
Answer: Classification of VitroGro® ECM as a Class III Medical Device under Rule 8 was determined by the Notified Body and advised to Tissue Therapies Ltd

Looks to me like someone's twisted the facts here for their benefit. I think its called Buck Passing. Its clearly the responsibility of the manufacturer to choose the classification. If there is a disagreement on the classification then the NRMA says, "In the event that the manufacturer and the notified body cannot agree on the classification, either party can refer the matter for a decision to the competent authority that designated the notified body. If doubt still exists, the European Commission, acting in conjunction with a regulatory committee composed of experts from the member states may be approached for a ruling. Similarly, the European Commission, in conjunction with the regulatory committee, may adapt the rules if experience shows this to be necessary."

Plenty of scope to make sure you get it right.

Looks like TIS wanted the classification 8 and BSI was prepared to do the business. Apparently they had done similar type products before under this ruling.

The statement by TIS on 30-10-2012 said it like this.
"Biomedical company, Tissue Therapies Limited (ASX: TIS) has been notified that the Medicines and Healthcare products Regulatory Agency (MHRA) review of VitroGro® ECM has confirmed classification of VitroGro® ECM as a Medical Device Class 3, but under Device Rule 13 instead of Device Rule 8, as was agreed earlier with the Notified Body."

Notice the last line, "as was agreed earlier with the Notified Body." That does not say "told by the Notified Body." The devil is in the detail.

I hope there are enough "FACTS" there for you dinner boys. Sorry if its spoiled it a little. Let me repeat it one more time.
. From the NRMA on classifications.
"It is for the manufacturer to initially determine the classification of their product(s)."

Expand

timkiely,

It appears that some of your research could be flawed as a result of quoting extracts from NRMA material instead of MHRA.

Regards........................................

TIS Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 6 more messages in this thread...

First 24 Last

Add TIS (ASX) to my watchlist

NZ company - tissue repair product, page-24

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News